GlassScriptPhysician profile
Stephen A Schulman
NPI 1760413173
$924.11
in general payments reported to CMS, 2019-2025
16 companies · $152 in 2025
The $152 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $143 · 2020: $130 · 2021: $151 · 2022: $133 · 2023: $164 · 2024: $51.55 · 2025: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $367.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $367.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $273.42 | 2019-2023 | Jornay Pm |
| Cranial Technologies, INC | $136.35 | 2019-2025 | Doc Band |
| Sanofi Pasteur INC. | $68.97 | 2021-2023 | |
| Glaxosmithkline, LLC. | $64.49 | 2019-2023 | Menveo, Bexsero, Pediarix |
| Viiv Healthcare Company | $58.06 | 2025 | Cabenuva |
| Corium, LLC | $47.45 | 2022-2023 | Azstarys |
| Pfizer INC. | $39.17 | 2021-2025 | |
| Sobi, INC | $38.47 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $36.21 | 2020 | |
| Merck Sharp & Dohme LLC | $32.49 | 2023-2024 | Proquad, Vaxelis, Vaxneuvance |
| Adlon Therapeutics L.P. | $29.57 | 2021 | |
| Cipher Pharmaceuticals US LLC | $26.26 | 2025 | Natroba, Spinosad |
| Alexion Pharmaceuticals, INC. | $25.00 | 2023 | Koselugo |
| Ultragenyx Pharmaceutical INC. | $18.69 | 2021 | |
| Seqirus USA INC | $17.70 | 2025 | Flucelvax |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $11.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Schulman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.